Acquisitions, Funding, Business, and Stock

16th October 2024, Mentioned in HISTalk https://histalk2.com/ – 

CVS Health will exit its infusion business and close or sell 29 related regional pharmacies. The company bought infusion company Coram for $2.1 billion in 2013.

UnitedHealth Group reports Q3 results: revenue up 9%, EPS $6.51 versus $6.24, beating expectations for both, but shares dropped sharply on the news. CEO Andrew Witty said in the earnings call that health system partnerships will provide significant opportunities. The company reported that the Change Healthcare cyberattack will cost it $705 million.

UK-based health tech market intelligence form Signify Research receives an $8 million investment from UK investment company BGF.